Associated Papers
Identification of genomic biomarkers of disease progression and survival in primary CNS lymphoma.
Geng H et al.
Blood Advances, 2025
39536287 (PubMed )
Supplement: BLOODA_ADV-2024-014460-mmc1.pdf
Molecular Characterization of Primary Mediastinal Large B-Cell Lymphomas.
Donzel M et al.
Cancers, 2023
37835560 (PubMed )
Supplement: cancers-15-04866-s001.zip › Suppl._Table._2.xlsx › Feuil1
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements.
Frauenfeld L et al.
Blood Advances, 2022
34654055 (PubMed )
Supplement: advancesADV2021006034-suppl1.pdf
Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease.
Chen BJ et al.
The American Journal of Surgical Pathology, 2019
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.
Bohers E et al.
Blood Cancer Journal, 2018
30069017 (PubMed )
Supplement: 41408_2018_111_MOESM2_ESM.pdf
Select a paper to view details